反应详情

Using general procedure A, 3-methylbenzylamine (30 μL, 0.23 mmol) and 4,6-dimethylpyrimidine-5-carboxylic acid [3-(4-oxo-piperidin-1-yl)-butyl]-amide (66 mg, 0.22 mmol) afforded 4,6-dimethyl-pyrimidine-5-carboxylic acid {3-[4-(3-methyl-benzylamino)-piperidin-1-yl]-butyl}-amide (65 mg, 72%).